Drug Discovery

Male animal bias in preclinical research isn’t scientifically justified and may be skewing our understanding of the brain.

Innovation in the ENT space is lacking. Lyra Therapeutics is, therefore, trying to create solutions for patient with unmet clinical needs.

Sitting Down With… Joan Mannick, Co-Founder and Chief Medical Officer at resTORbio, Massachusetts, USA.

Can the innate immune system be reprogrammed to fight cancer? Inmune Bio believes the answer is yes.

Georg Winter has cinched Eppendorf's 2019 Young European Scientist award.

SPaeDD, a collaborative effort between industry, academia and contractors, is helping to accelerate pediatric drug development in the UK..

Will the antibiotic apocalypse kill us all?

Will antibody drug conjugates live up to the ever-growing expectations surrounding them?

At the helm of SkinBioTherapeutics, Catherine O’Neill and her team are exploring the ways in which probiotic bacteria can be used topically.

Could blood cells provide the ideal environment to test new drugs for neuropsychiatric disorders?